NCT01696071 - Comparison of Two Daily Dose Regimens of Tiotropium 5 µg Once Daily and Tiotropium 2.5 µg Twice Daily for 4 Weeks on Top of Maintenance Therapy With Inhaled Corticosteroid Controller Medication | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

June 30, 2013

Study Completion Date

June 30, 2013

Conditions

Asthma

Interventions

DRUG

Tiotropium 5 mcg qd

2 puffs (2.5 mcg each) in the evening 5 mcg in total and 2 puffs of matching placebo in the morning

DRUG

Tiotropium 2.5 mcg bid

2 puffs (1.25 mcg each) twice daily, in the evening and in the morning, 5 mcg in total

Trial Locations (22)

205.441.43004 Boehringer Ingelheim Investigational Site, Grieskirchen

205.441.43003 Boehringer Ingelheim Investigational Site, Linz

205.441.43001 Boehringer Ingelheim Investigational Site, Thalheim bei Wels

205.441.43002 Boehringer Ingelheim Investigational Site, Wels

205.441.49015 Boehringer Ingelheim Investigational Site, Berlin

205.441.49003 Boehringer Ingelheim Investigational Site, Frankfurt

205.441.49014 Boehringer Ingelheim Investigational Site, Frankfurt

205.441.49007 Boehringer Ingelheim Investigational Site, Großhansdorf

205.441.49005 Boehringer Ingelheim Investigational Site, Hanover

205.441.49004 Boehringer Ingelheim Investigational Site, Leipzig

205.441.49010 Boehringer Ingelheim Investigational Site, Lübeck

205.441.49013 Boehringer Ingelheim Investigational Site, Mannheim

205.441.49001 Boehringer Ingelheim Investigational Site, Neu-Isenburg

205.441.49002 Boehringer Ingelheim Investigational Site, Wiesbaden

205.441.49011 Boehringer Ingelheim Investigational Site, Wiesloch

205.441.36003 Boehringer Ingelheim Investigational Site, Cegléd

205.441.36002 Boehringer Ingelheim Investigational Site, Gödöllő

205.441.36001 Boehringer Ingelheim Investigational Site, Pécs

205.441.36005 Boehringer Ingelheim Investigational Site, Százhalombatta

205.441.36004 Boehringer Ingelheim Investigational Site, Szigetszentmiklós

205.441.38601 Boehringer Ingelheim Investigational Site, Golnik

205.441.38602 Boehringer Ingelheim Investigational Site, Kamnik